| NPs | nanoparticles |
| EPR | enhanced permeability and retention effect |
| PEG | polyethylene glycol |
| TME | tumor microenvironment |
| OMVs | outer membrane vesicles |
| DMVs | bilayer membrane vesicles |
| BMVs | bacterial membrane vesicles |
| BGs | bacterial ghosts |
| BSPs | bacterial spores |
| E. coli | Escherichia coli |
| EcN | E. coli Nissle 1917 |
| S. boulardii | Saccharomyces boulardii |
| L. reuteri | Lactobacillus reuteri |
| L. casei | Lactobacillus casei |
| L. rhamnosus | Lactobacillus rhamnosus |
| L. m | Listeria monocytogenes |
| LA | Lactobacillus acidophilus |
| B. infantis | Bifidobacterium infantis |
| B. breve | Bifidobacterium breve |
| BB | Bifidobacterium bifidum |
| LPS | lipopolysaccharide |
| TNF-α | tumor necrosis factor-α |
| IL-6 | interleukin-6 |
| IL-β | interleukin-β |
| EOMVs | explosive outer membrane vesicles |
| OIMVs | outer inner membrane vesicles |
| CMVs | cytoplasmic membrane vesicles |
| PAMPs | pathogen-associated molecular patterns |
| DC | dendritic |
| αPD-1 | Anti-programmed death-1 |
| PD-1 | programmed death-1 |
| PTT | photothermal therapy |
| ClyA | cytolysin |
| RBC | red blood cell |
| TLR4 | toll-like receptor 4 |
| MDR | multidrug resistance |
| DOX | doxorubicin |
| RGD | Arg-Gly-Asp |
| COVID-19 | coronavirus disease-19 |
| PDA | polydopamine |
| OVA | ovalbumin antigen |
| HSA | human serum albumin |
| LDH | layered-double-hydroxide |
| NIR | near-infrared |
| PLGA | Poly (lactic-co-glycolic acid) |
| 5-FU | 5-fluorouracil |
| BBB | blood–brain barrier |
| BCG | Bacillus Calmette-Guerin |